Year All20242023202220212020201920182017201620152014 Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action January 05, 2023 Read More Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD December 20, 2022 Read More Abivax to attend the J.P. Morgan 41st Annual Healthcare Conference December 14, 2022 Read More Abivax releases the results of its November 9, 2022 ad hoc ordinary and extraordinary general meeting November 14, 2022 Read More Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis October 11, 2022 Read More Abivax announces ad hoc ordinary and extraordinary general meeting on November 9, 2022 October 03, 2022 Read More Abivax announces the release of its 2022 half-year financial report September 30, 2022 Read More Abivax abstract on obefazimod phase 2b results selected for moderated poster presentation at UEG Week 2022 September 27, 2022 Read More Abivax presents first-half 2022 financial results and operations update September 15, 2022 Read More Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology September 06, 2022 Read More
Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action January 05, 2023 Read More
Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD December 20, 2022 Read More
Abivax releases the results of its November 9, 2022 ad hoc ordinary and extraordinary general meeting November 14, 2022 Read More
Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis October 11, 2022 Read More
Abivax announces ad hoc ordinary and extraordinary general meeting on November 9, 2022 October 03, 2022 Read More
Abivax abstract on obefazimod phase 2b results selected for moderated poster presentation at UEG Week 2022 September 27, 2022 Read More
Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology September 06, 2022 Read More
